Host Genetic Background and Gut Microbiota Contribute to Differential Metabolic Responses to Fructose Consumption in Mice

Ahn, In Sook; Lang, Jennifer M.; Olsen, Christine; Ying, Zhe; Zhang, Guanglin; Byun, Hyae Ran; Zhao, Yuqi; Kurt, Zeyneb; Lusis, Aldons J.; Hsaio, Elaine; Gómez‐Pinilla, Fernando; Yang, Xia

doi:10.1101/439786

Cited by 1 publication

(1 citation statement)

References 53 publications

(66 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our previous studies used FVB mice. The two different mouse strains are known to possess significantly different basal microbiota (Ahn et al, 2018). Thus, the difference in mouse strain may contribute to the different magnitude of pregnancyinduced change for some DMETs between this and our previous studies.…”

Section: Discussionmentioning

confidence: 57%

Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy

Han¹,

Wang²,

Shi³

et al. 2020

Drug Metab Dispos

View full text Add to dashboard Cite

The microbiome and pregnancy are known to alter drug disposition, yet the interplay of the two physiologic factors on the expression and/or activity of drug metabolizing enzymes and transporters (DMETs) is unknown. This study investigated the effects of microbiome on host hepatic DMETs in mice during pregnancy by comparing four groups of conventional (CV) and germ-free (GF) female mice and pregnancy status, namely, CV nonpregnant, GF non-pregnant, CV pregnant, and GF pregnant mice. Transcriptomic and targeted proteomics of hepatic DMETs were profiled by using multiomics. Plasma bile acid and steroid hormone levels were quantified by liquid chromatography tandem mass spectrometry. CYP3A activities were measured by mouse liver microsome incubations. The trend of pregnancy-induced changes in the expression or activity of hepatic DMETs in CV and GF mice was similar; however, the magnitude of change was noticeably different. For certain DMETs, pregnancy status had paradoxical effects on mRNA and protein expression in both CV and GF mice. For instance, the mRNA levels of Cyp3a11, the murine homolog of human CYP3A4, were decreased by 1.7-fold and 3.3-fold by pregnancy in CV and GF mice, respectively; however, the protein levels of CYP3A11 were increased similarly ∼twofold by pregnancy in both CV and GF mice. Microsome incubations revealed a marked induction of CYP3A activity by pregnancy that was 10-fold greater in CV mice than that in GF mice. This is the first study to show that the microbiome can alter the expression and/or activity of hepatic DMETs in pregnancy. SIGNIFICANCE STATEMENTWe demonstrated for the first time that microbiome and pregnancy can interplay to alter the expression and/or activity of hepatic drug metabolizing enzymes and transporters. Though the trend of pregnancy-induced changes in the expression or activity of hepatic drug metabolizing enzymes and transporters in conventional and germ-free mice was similar, the magnitude of change was noticeably different.

show abstract

Section: Discussionmentioning

confidence: 57%